(Q45111719)

9 December 2017

title

Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats (English)

1 reference

9 December 2017

0 references

0 references

0 references

F L Smith

1

1 reference

9 December 2017

K Fujimori

series ordinal

2

1 reference

9 December 2017

J Lowe

series ordinal

3

1 reference

9 December 2017

S P Welch

series ordinal

4

1 reference

9 December 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Pharmacology, Biochemistry and Behavior

9 December 2017

published in

1 reference

9 December 2017

volume

60

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

183-191

1 reference

Pharmacological and behavioral evaluation of alkylated anandamide analogs

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid‐mediated blockade of long‐term potentiation in the rat hippocampal slice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Further evidence validating adjuvant arthritis as an experimental model of chronic pain in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Adjuvant-induced arthritis in rats: A possible animal model of chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Formation of [Leu5]enkephalin from dynorphin A(1-8) by rat central nervous tissue in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Anandamides: tolerance and cross-tolerance to delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

The role of PGE2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Opioid peptide processing and receptor selectivity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Morphine self-administration in the rat during adjuvant-induced arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Inflammation of the hind limb as a model of unilateral, localized pain: influence on multiple opioid systems in the spinal cord of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

The anti-inflammatory effects of LY178002 and LY256548

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Anti-inflammatory effects of LY221068 and LY269415.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Time-dependent changes in the activity of opioid systems in the spinal cord of monoarthritic rats--a release and in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Antisense oligodeoxynucleotides to the kappa-1 receptor block the antinociceptive effects of delta 9-THC in the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrazone (NalBZH).

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2897%2900583-2

7 January 2021

10.1016/S0091-3057(97)00583-2

Identifiers

DOI

1 reference

9 December 2017

1 reference